Top

Published in:

Open Access 18-12-2023 | Amyotrophic Lateral Sclerosis | Original Article

Cognitive function in amyotrophic lateral sclerosis: a cross-sectional and prospective pragmatic clinical study with review of the literature

Authors: Adamantios Katerelos, Panagiotis Alexopoulos, Polychronis Economou, Panagiotis Polychronopoulos, Elisabeth Chroni

Published in: Neurological Sciences | Issue 5/2024

Abstract

Background

Amyotrophic lateral sclerosis (ALS) can present with either bulbar or spinal symptoms, and in some cases, both types of symptoms may be present. In addition, cognitive impairment has been observed in ALS. The study aimed to evaluate the frontal and general cognitive performance in ALS not only cross-sectionally but also longitudinally.

Methods and materials

The Frontal Assessment Battery (FAB) and the Montreal Cognitive Assessment (MoCA) were employed to assess cognitive function in 52 adults with ALS and 52 cognitively healthy individuals. The statistical analyses encompassed the Pearson Chi square test, the Skillings-Mack test, the Spearman’s rank correlation coefficient, and the Proportional Odds Logistic Regression Model (POLR).

Results

Cross-sectionally, lower cognitive performance was associated with ALS diagnosis, older age, and motor functional decline. The cognitive impairment of individuals with bulbar and spinal-bulbar symptoms showed faster deterioration compared to those with spinal symptoms. The spinal subgroup consistently performed worst in delayed recall and attention, while the spinal-bulbar and bulbar subgroups exhibited inferior scores in delayed recall, attention, visuospatial skills, orientation, and verbal fluency.

Conclusion

The incorporation of cognitive screening in the diagnostic workup of ALS may be beneficial, as early detection can enhance symptom management and improve the quality of life for both individuals with ALS and their care partners.

Available only for authorised users

Wright AF (2005) Neurogenetics II: complex disorders. J Neurol Neurosurg Psychiatry 76(5):623–631. https://doi.org/10.1136/jnnp.2004.047704CrossRefPubMedPubMedCentral

Ravits J, La Spada AR (2009) ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73(10):805–811. https://doi.org/10.1212/wnl.0b013e3181b6bbbdCrossRefPubMedPubMedCentral

Stipancic KL, Yunusova Y, Campbell TF, Wang J, Berry J, Green JR (2021) Two distinct clinical phenotypes of bulbar motor impairment in amyotrophic lateral sclerosis. Frontiers in Neurology 12. https://doi.org/10.3389/fneur.2021.664713

Turner MR, Wicks P, Brownstein CA, Massagli MP, Toronjo M, Talbot K, Al-Chalabi A (2010) Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82(8):853–854. https://doi.org/10.1136/jnnp.2010.208413CrossRefPubMed

Segura T, Medrano IH, Collazo S, Maté C, Sguera C, Del Rio-Bermúdez C, Casero H, Salcedo IH, García-García J, Alcahut-Rodríguez C, Taberna M (2023) Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence. Scientific Reports 13(1). https://doi.org/10.1038/s41598-023-27863-2

Radunović A, Annane D, Rafiq M, Brassington R, Mustfa N (2017) Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. The Cochrane Library 2018(6). https://doi.org/10.1002/14651858.cd004427.pub4

Strong MJ, Abrahams S, Goldstein LH, Woolley S, McLaughlin P, Snowden JS, Mioshi E, Roberts A, Benatar M, Hortobágyi T, Rosenfeld J, Silani V, Ince PG, Turner MR (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18(3–4):153–174. https://doi.org/10.1080/21678421.2016.1267768CrossRefPubMed

Phukan J, Pender N, Hardiman O (2007) Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 6(11):994–1003. https://doi.org/10.1016/s1474-4422(07)70265-xCrossRefPubMed

Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey L, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130–133. https://doi.org/10.1126/science.1134108CrossRefPubMed

10.

Rippon GA, Scarmeas N, Gordon PH, Murphy PL, Albert SM, Mitsumoto H, Marder K, Rowland LP, Stern Y (2006) An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol 63(3):345. https://doi.org/10.1001/archneur.63.3.345CrossRefPubMed

11.

Mantovan MC, Baggio L, Barba GD, Smith PA, Pegoraro E, Sorarù G, Bonometto P, Angelini C (2003) Memory deficits and retrieval processes in ALS¹. Eur J Neurol 10(3):221–227. https://doi.org/10.1046/j.1468-1331.2003.00607.xCrossRefPubMed

12.

Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, O’Brien C, Phukan J, Lynch C, Pender N, Hardiman O (2013) Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 80(17):1590–1597. https://doi.org/10.1212/wnl.0b013e31828f18acCrossRefPubMed

13.

Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, Graf M, Uttner I, Muche R, Ludolph AC (2005) Cognitive function in bulbar– and spinal–onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. Journal of Neurology 252(7), 772–781. https://doi.org/10.1007/s00415-005-0739-6

14.

Abrahams S, Goldstein LH, Kew J, Brooks DJ, Lloyd C, Frith CD, Leigh PN (1996) Frontal lobe dysfunction in amyotrophic lateral sclerosis. Brain 119(6):2105–2120. https://doi.org/10.1093/brain/119.6.2105CrossRefPubMed

15.

Kew J, Goldstein LH, Leigh PN, Abrahams S, Cosgrave N, Passingham RE, Frackowiak RSJ, Brooks DJ (1993) The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis: a neuropsychological and positron emission tomography study. Brain 116(6):1399–1423. https://doi.org/10.1093/brain/116.6.1399CrossRefPubMed

16.

Ludolph AC, Langen K, Regard M, Herzog H, Kemper B, Kuwert T, Böttger I, Feinendegen LE (1992) Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 85(2):81–89. https://doi.org/10.1111/j.1600-0404.1992.tb04003.xCrossRefPubMed

17.

Talbot PR, Goulding P, Lloyd JJ, Snowden JS, Neary D, Testa HJ (1995) Inter-relation between “classic” motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry 58(5):541–547. https://doi.org/10.1136/jnnp.58.5.541CrossRefPubMedPubMedCentral

18.

Jeong YK, Park KC, Cho SS, Kim EJ, Kang S, Kim SE, Kang E, Na DL (2005) Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease. Neurology 64(4):734–736. https://doi.org/10.1212/01.wnl.0000152047.58767.9dCrossRefPubMed

19.

Andreadou E, Sgouropoulos P, Varelas PN, Gouliamos A, Papageorgiou C (1998) Subcortical frontal lesions on MRI in patients with motor neurone disease. Neuroradiology 40(5):298–302. https://doi.org/10.1007/s002340050588CrossRefPubMed

20.

Strong MJ (2001) Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression. Can J Neurol Sci 28(4):283–298. https://doi.org/10.1017/s0317167100001505CrossRefPubMed

21.

Gallassi R, Montagna P, Ciardulli C, Lorusso S, Mussuto V, Stracciari A (2009) Cognitive impairment in motor neuron disease. Acta Neurol Scand 71(6):480–484. https://doi.org/10.1111/j.1600-0404.1985.tb03231.xCrossRef

22.

Anderson V, Cairns NJ, Leigh PN (1995) Involvement of the amygdala, dentate and hippocampus in motor neuron disease. J Neurol Sci 129:75–78. https://doi.org/10.1016/0022-510x(95)00069-eCrossRefPubMed

23.

Trojsi F, Di Nardo F, Santangelo G, Siciliano M, Femiano C, Passaniti C, Caiazzo G, Fratello M, Cirillo M, Monsurrò MR, Esposito F, Tedeschi G (2017) Resting state fMRI correlates of Theory of Mind impairment in amyotrophic lateral sclerosis. Cortex 97:1–16. https://doi.org/10.1016/j.cortex.2017.09.016CrossRefPubMed

24.

Osborne RA, Sekhon R, Johnston W, Kalra S (2014) Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. J Neurol Sci 336(1–2):191–196. https://doi.org/10.1016/j.jns.2013.10.038CrossRefPubMed

25.

Oskarsson B, Quan D, Rollins YD, Neville HE, Ringel SP, Arciniegas DB (2010) Using the Frontal Assessment Battery to identify executive function impairments in amyotrophic lateral sclerosis: a preliminary experience. Amyotroph Lateral Scler 11(1–2):244–247. https://doi.org/10.3109/17482960903059588CrossRefPubMed

26.

Ahn S, Kim S, Kim J, Kim S, Kim SH, Sung J, Lee K, Hong Y (2011) Frontal Assessment Battery to evaluate frontal lobe dysfunction in ALS patients. Can J Neurol Sci 38(2):242–246. https://doi.org/10.1017/s0317167100011409CrossRefPubMed

27.

Beeldman E, Govaarts R, Visser M, Twennaar MK, Van Der Kooi AJ, Van Den Berg LH, Veldink JH, Pijnenburg YA, De Haan RJ, Schmand B, Raaphorst J (2020) Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 91(7):779–780. https://doi.org/10.1136/jnnp-2020-322992CrossRefPubMed

28.

Bersano E, Sarnelli MF, Solara V, Iazzolino B, Peotta L, De Marchi F, Facchin A, Moglia C, Canosa A, Calvo A, Chiò A, Mazzini L (2020) Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21(5–6):373–379. https://doi.org/10.1080/21678421.2020.1771732CrossRefPubMed

29.

Bock M, Duong Y, Kim A, Allen IE, Murphy J, Lomen-Hoerth C (2017) Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis. Neurology 7(6):488–498. https://doi.org/10.1212/cpj.0000000000000397CrossRefPubMedPubMedCentral

30.

Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G (2022) Amyotrophic lateral sclerosis. The Lancet 400(10360):1363–1380. https://doi.org/10.1016/s0140-6736(22)01272-7CrossRef

31.

Alexopoulos P, Skondra M, Kontogianni E, Vratsista A, Frounta M, Konstantopoulou G, Aligianni SΙ, Charalampopoulou M, Lentzari I, Gourzis P, Kliegel M, Εconomou P, Politis A (2021) Validation of the cognitive telephone screening instruments COGTEL and COGTEL+ in identifying clinically diagnosed neurocognitive disorder due to Alzheimer’s disease in a naturalistic clinical setting. Journal of Alzheimer’s Disease 83(1):259–268. https://doi.org/10.3233/jad-210477CrossRefPubMedPubMedCentral

32.

Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a Frontal Assessment Battery at bedside. Neurology 55(11):1621–1626. https://doi.org/10.1212/wnl.55.11.1621CrossRefPubMed

33.

Boban M, Malojčić B, Mímica N, Vuković S, Zrilić I (2012) The Frontal Assessment Battery in the differential diagnosis of dementia. J Geriatr Psychiatry Neurol 25(4):201–207. https://doi.org/10.1177/0891988712464821CrossRefPubMed

34.

Ringholz G, Appel SH, Bradshaw M, Cooke N, Mosnik D, Schulz PE (2005) Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65(4):586–590. https://doi.org/10.1212/01.wnl.0000172911.39167.b6CrossRefPubMed

35.

Strong MJ (2008) The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 9(6):323–338. https://doi.org/10.1080/17482960802372371CrossRefPubMed

36.

Terada T, Obi T, Miyajima H, Mizoguchi K (2010) Assessing frontal lobe function in patients with amyotrophic lateral sclerosis by Frontal Assessment Battery. Rinshō Shinkeigaku 50(6):379–384. https://doi.org/10.5692/clinicalneurol.50.379CrossRefPubMed

37.

Floris G, Borghero G, Chiò A, Secchi L, Cannas A, Sardu C, Calvo A, Moglia C, Marrosu MG (2011) Cognitive screening in patients with amyotrophic lateral sclerosis in early stages. Amyotroph Lateral Scler 13(1):95–101. https://doi.org/10.3109/17482968.2011.605453CrossRefPubMed

38.

Aiello EN, Solca F, Torre S, Carelli L, Ferrucci R, Priori A, Verde F, Ticozzi N, Silani V, Poletti B (2022) Feasibility and diagnostics of the Frontal Assessment Battery (FAB) in amyotrophic lateral sclerosis. Neurol Sci 44(2):587–592. https://doi.org/10.1007/s10072-022-06438-5CrossRefPubMedPubMedCentral

39.

Miki E, Kataoka T, Okamura H (2012) Clinical usefulness of the Frontal Assessment Battery at bedside (FAB) for elderly cancer patients. Support Care Cancer 21(3):857–862. https://doi.org/10.1007/s00520-012-1595-4CrossRefPubMed

40.

Appollonio I, Leone ME, Isella V, Piamarta F, Consoli T, Villa ML, Forapani E, Russo A, Nichelli PF (2005) The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci 26(2):108–116. https://doi.org/10.1007/s10072-005-0443-4CrossRefPubMed

41.

Lima CF, Meireles L, Fonseca R, Castro SL, Garrett C (2008) The Frontal Assessment Battery (FAB) in Parkinson’s disease and correlations with formal measures of executive functioning. J Neurol 255(11):1756–1761. https://doi.org/10.1007/s00415-008-0024-6CrossRefPubMed

42.

Barulli MR, Fontana A, Panza F, Copetti M, Bruno S, Tursi M, Iurillo A, Tortelli R, Capozzo R, Simone IL, Logroscino G (2015) Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study. BMJ Open 5(9):e007069. https://doi.org/10.1136/bmjopen-2014-007069CrossRefPubMedPubMedCentral

43.

Aiello EN, Solca F, Torre S, Carelli, L, Ferrucci R, Priori A, Verde F, Silani V, Ticozzi N, Poletti B (2022) Diagnostics and clinical usability of the Montreal Cognitive Assessment (MoCA) in amyotrophic lateral sclerosis. Front Psychol 13. https://doi.org/10.3389/fpsyg.2022.1012632

44.

Nasreddine Z, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.xCrossRefPubMed

45.

Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169(1–2):13–21. https://doi.org/10.1016/s0022-510x(99)00210-5CrossRefPubMed

46.

Beeldman E, Raaphorst J, Twennaar MK, Visser M, Schmand B, De Haan RJ (2015) The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry 87(6):611–619. https://doi.org/10.1136/jnnp-2015-310734CrossRefPubMed

47.

Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, Lynch C, Pender N, Hardiman O (2011) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83(1):102–108. https://doi.org/10.1136/jnnp-2011-300188CrossRefPubMed

48.

Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH (1996) Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 61(5):450–455. https://doi.org/10.1136/jnnp.61.5.450CrossRefPubMedPubMedCentral

49.

Raaphorst J, Beeldman E, Visser M, De Haan RJ, Schmand B (2012) A systematic review of behavioural changes in motor neuron disease. Amyotroph Lateral Scler 13(6):493–501. https://doi.org/10.3109/17482968.2012.656652CrossRefPubMed

50.

Gordon PH, Cheng B, Salachas F, Pradat P, Bruneteau G, Corcia P, Lacomblez L, Meininger V (2010) Progression in ALS is not linear but is curvilinear. J Neurol 257(10):1713–1717. https://doi.org/10.1007/s00415-010-5609-1CrossRefPubMed

51.

Chiò A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, Barberis M, Corrado L, D’Alfonso S, Bersano E, Sarnelli MF, Solara V, Zucchetti JP, Peotta L, Iazzolino B, Mazzini L, Mora G, Calvo A (2019) Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology 93(10):e984–e994. https://doi.org/10.1212/wnl.0000000000008063CrossRefPubMedPubMedCentral

52.

Gordon PH, Goetz RR, Rabkin JG, Dalton K, McElhiney M, Hays AP, Marder K, Stern Y, Mitsumoto H (2010) A prospective cohort study of neuropsychological test performance in ALS. Amyotroph Lateral Scler 11(3):312–320. https://doi.org/10.3109/17482961003622585CrossRefPubMed

53.

Woolley S, Goetz R, Factor-Litvak P, Murphy J, Hupf J, Lomen‐Hoerth C, Andrews H, Heitzman D, Bedlack R, Katz J, Barohn RJ, Sorenson EJ, Oskarsson B, Filho AF, Kasarskis EJ, Mozaffar T, Nations SP, Swenson A, Koczon-Jaremko A, Mitsumoto H (2018) Longitudinal screening detects cognitive stability and behavioral deterioration in ALS patients. Behav Neurol 2018l 1–7. https://doi.org/10.1155/2018/5969137

54.

Brettschneider J, Del Tredici K, Toledo JB, Robinson J, Irwin DJ, Grossman M, Suh E, Van Deerlin VM, Wood EM, Baek YM, Kwong LK, Lee EB, Elman L, McCluskey L, Fang L, Feldengut S, Ludolph AC, Lee VM, Braak H, Trojanowski JQ (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74(1):20–38. https://doi.org/10.1002/ana.23937CrossRefPubMedPubMedCentral

55.

Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K (2013) Amyotrophic lateral sclerosis—a model of corticofugal axonal spread. Nat Rev Neurol 9(12):708–714. https://doi.org/10.1038/nrneurol.2013.221CrossRefPubMedPubMedCentral

56.

Cykowski MD, Powell SZ, Peterson LE, Appel JW, Rivera AL, Takei H, Chang ET, Appel SH (2017) Clinical significance of TDP-43 neuropathology in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 76(5):402–413. https://doi.org/10.1093/jnen/nlx025CrossRefPubMedPubMedCentral

57.

Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna KP, Lynch C, McLaughlin RL, Iyer P, O’Brien C, Phukan J, Wynne B, Bokde AL, Bradley DG, Pender N, Al-Chalabi A, Hardiman O (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 11(3):232–240. https://doi.org/10.1016/s1474-4422(12)70014-5CrossRefPubMedPubMedCentral

58.

Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, Brunetti M, Ossola I, Lo Presti A, Cammarosano S, Canosa A, Chiò A (2014) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168–173. https://doi.org/10.1136/jnnp-2013-307223CrossRefPubMed

59.

Woolley S, Goetz R, Factor-Litvak P, Murphy J, Hupf J, Garofalo DC, … Mitsumoto H (2018) longitudinal screening detects cognitive stability and behavioral deterioration in als patients. Behav Neurol 2018: 5969137. https://doi.org/10.1155/2018/5969137

60.

Jellinger KA (2023) The spectrum of cognitive dysfunction in amyotrophic lateral sclerosis: an update. Int J Mol Sci 24(19):14647. https://doi.org/10.3390/ijms241914647CrossRefPubMedPubMedCentral

61.

Borrego-Écija S, Turon-Sans J, Ximelis T, Aldecoa I, Molina-Porcel L, Povedano M, Rubio MA, Gámez J, Cano A, Paré-Curell M, Bajo L, Sotoca J, Clarimón J, Balasa M, Antonell A, Lladó A, Sánchez-Valle R, Rojas-García R, Gelpi E (2021) Cognitive decline in amyotrophic lateral sclerosis: neuropathological substrate and genetic determinants. Brain pathology (Zurich, Switzerland) 31(3):e12942. https://doi.org/10.1111/bpa.12942CrossRefPubMed

62.

Abramzon YA, Fratta P, Traynor BJ, Chia R (2020) The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci 14:42. https://doi.org/10.3389/fnins.2020.00042CrossRefPubMedPubMedCentral

63.

Tjokrowijoto P, Phillips M, Ceslis A, Henderson RD, McCombe PA, Robinson G (2023) Sensitivity and specificity of the ECAS in identifying executive function and social cognition deficits in MND. Amyotroph Lateral Scler Frontotemporal Degeneration 24(5–6):466–474. https://doi.org/10.1080/21678421.2023.2188053CrossRef

64.

Gagliardi D, Meneri M, Saccomanno D, Bresolin N, Pietro Comi G, Corti S (2019) Diagnostic and prognostic role of blood and cerebrospinal fluid and blood neurofilaments in amyotrophic lateral sclerosis: a review of the literature. Int J Mol Sci 20(17):4152. https://doi.org/10.3390/ijms20174152CrossRefPubMedPubMedCentral

65.

Riku Y, Yoshida M, Tamura T, Kamijo M, Yasui K, Kameyama T, Katsuno M, Sobue G, Iwasaki Y (2021) Unexpected postmortem diagnoses in cases of clinically diagnosed amyotrophic lateral sclerosis. Neuropathology 41(6):457–467. https://doi.org/10.1111/neup.12744CrossRefPubMed

66.

Agosta F, Ferraro PM, Riva N, Spinelli EG, Chiò A, Canu E, Valsasina P, Lunetta C, Iannaccone S, Copetti M, Prudente E, Comi G, Falini A, Filippi M (2016) Structural brain correlates of cognitive and behavioral impairment in MND. Hum Brain Mapp 37(4):1614–1626. https://doi.org/10.1002/hbm.23124CrossRefPubMedPubMedCentral

67.

Agosta F, Spinelli EG, Filippi M (2018) Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses. Expert Rev Neurother 18(5):395–406. https://doi.org/10.1080/14737175.2018.1463160CrossRefPubMed

68.

Willekens S, Van Weehaeghe D, Van Damme P, Van Laere K (2016) Positron emission tomography in amyotrophic lateral sclerosis: towards targeting of molecular pathological hallmarks. Eur J Nucl Med Mol Imaging 44(3):533–547. https://doi.org/10.1007/s00259-016-3587-yCrossRefPubMed

69.

Lulé D, Böhm S, Müller H, Aho-Özhan HEA, Keller J, Gorges M, Loose M, Weishaupt JH, Uttner I, Pinkhardt EH, Kassubek J, Del Tredici K, Braak H, Abrahams S, Ludolph AC (2018) Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis. Cortex 101:163–171. https://doi.org/10.1016/j.cortex.2018.01.004CrossRefPubMed

70.

Poletti B, Carelli L, Solca F, Lafronza A, Pedroli E, Faini A, Ticozzi N, Ciammola A, Meriggi P, Cipresso P, Lulé D, Ludolph AC, Riva G, Silani V (2017) An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS. J Neurol 264(6):1136–1145. https://doi.org/10.1007/s00415-017-8506-zCrossRefPubMed

71.

Carelli L, Solca F, Faini A, Meriggi P, Sangalli D, Cipresso P, Riva G, Ticozzi N, Ciammola A, Silani V, Poletti B (2017) Brain-computer interface for clinical purposes: cognitive assessment and rehabilitation. Biomed Res Int 2017:1–11. https://doi.org/10.1155/2017/1695290CrossRef

Title: Cognitive function in amyotrophic lateral sclerosis: a cross-sectional and prospective pragmatic clinical study with review of the literature
Authors: Adamantios Katerelos
Panagiotis Alexopoulos
Polychronis Economou
Panagiotis Polychronopoulos
Elisabeth Chroni
Publication date: 18-12-2023
Publisher: Springer International Publishing
Keyword: Amyotrophic Lateral Sclerosis
Published in: Neurological Sciences / Issue 5/2024
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-023-07262-1

Advances in Alzheimer's

Alzheimer's Disease Independent Medical Education

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:

Lilly

Developed by: Springer Healthcare IME

Learn more

2024 ESC Congress

Springer Medicine

Cognitive function in amyotrophic lateral sclerosis: a cross-sectional and prospective pragmatic clinical study with review of the literature

Abstract

Background

Methods and materials

Results

Conclusion

Advances in Alzheimer's

2024 ESC Congress

Springer Medicine

Abstract

Background

Methods and materials

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2024

Impact of delirium on acute stroke outcomes: A systematic review and meta-analysis

The first interim analysis of Italian patients enrolled in the real-world, Pan-European, prospective, observational, phase 4 PEARL study of fremanezumab effectiveness

Development and internal validation of a prognostic model for loss of balance and falls in mid- to late-stage Parkinson’s disease

Cerebral hemodynamics and cognitive functions in the acute and subacute stage of mild ischemic stroke: a longitudinal pilot study

Lemierre’s: a forgotten disease and a rare cause of cranial neuropathy – a case report

Neurosurgical treatment and outcome patterns in patients with meningioma in South Moravian region—a population-based study

Advances in Alzheimer's